Big Data Framework for Predicting Infectious Diseases to improve Healthcare by Discovering New Symptom Patterns

Author:

mounir amal1,Marie Mohamed Ibrahim2,Abd-Elhamid Laila2

Affiliation:

1. Zagazig University

2. Helwan University

Abstract

Abstract

Infectious disease control is one of the most thrilling opportunities form using big data, where these streams of novel data can be used to improve timeliness for preventing. Various public and private sector Healthcare providers generate, store, and analyse big data to improve the services they provide. Lately, the COVID-19-new Corona virus outbreak has put human health, life, production, social connections, and international relations in grave danger. Consequently, big data technologies have been crucial in the pandemic response. Infectious disease occurs when a person has a disease by a pathogen from another person. It is a problem that causes harm for both individual and macro scales. In addition, infectious illness patterns are unknown, which complicate the prediction process. This study aims to create big data framework to predict infectious diseases by discovering new symptoms patterns to enhance healthcare infection prevention and control. To achieve this goal, machine learning algorithms K-Nearest Neighbors (K-NN) and Random Forest (RF) were used to clean and maintain big data from December 2019 to June 2020. Additionally, the mining model FP-growth and Park, Chen, and Yu (PCY) of China were applied to discover new symptom rules. The results show that the RF model performs better than K-NN with accuracy rates of 97%, and the PCY model performs better than FP-growth with an accuracy rate of 98%. These results highlight the potential of big data and machine learning in identifying patterns and predicting infectious diseases, which can ultimately improve public health outcomes.

Publisher

Research Square Platform LLC

Reference13 articles.

1. Pathology and therapeutics of COVID-19: a review;Anwar H;Int.J. Med. Stud.,2020

2. Mind the Scales: Harnessing Spatial Big Data for Infectious Disease Surveillance and Inference;Lee EC;J Infect Dis,2016

3. Agrawal, R., Imielinski, T., and Swami, A. Mining association rules between sets of items in large databases. In Buneman, P., and Jajodia, S., (eds.). Proceedings of ACM SIGMOD Conference on Management of Data, 1993 (SIGMOD93), 207-2 16.

4. Bansal S, Chowell G, Simonsen L, Vespignani A, Viboud C. Big Data for Infectious Disease Surveillance and Modeling. J Infect Dis. 2016;214(suppl_4):S375-S379. doi:10.1093/infdis/jiw400Bauchner H, Fontanarosa PB. Randomized Clinical Trials and COVID-19: Managing Expectations. JAMA. 2020;323(22):2262–2263. doi:10.1001/jama.2020.8115

5. Jonathan Grein, Norio Ohmagari, Daniel Shin, Diaz George, Erika Asperges, Antonella Castagna, Torsten Feldt, Gary Green, Margaret L. Green, Fran ̃A§oisXavier Lescure, et al., Compassionate use of remdesivir for patients with severe covid-19, N. Engl. J. Med. 382 (24) (2020).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3